ResMed (RMD) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

ResMed Revenue Highlights

Latest Revenue (Y)

$4.69B

Latest Revenue (Q)

$1.22B

Main Segment (Y)

Sleep And Respiratory

Main Geography (Y)

U [S]

ResMed Revenue by Period

ResMed Revenue by Year

Date	Revenue	Change
2024-06-30	$4.69B	10.95%
2023-06-30	$4.22B	18.02%
2022-06-30	$3.58B	11.93%
2021-06-30	$3.20B	8.11%
2020-06-30	$2.96B	13.44%
2019-06-30	$2.61B	11.38%
2018-06-30	$2.34B	13.23%
2017-06-30	$2.07B	12.40%
2016-06-30	$1.84B	9.52%
2015-06-30	$1.68B	7.97%
2014-06-30	$1.55B	2.68%
2013-06-30	$1.51B	10.66%
2012-06-30	$1.37B	10.08%
2011-06-30	$1.24B	13.80%
2010-06-30	$1.09B	18.64%
2009-06-30	$920.74M	10.22%
2008-06-30	$835.40M	16.62%
2007-06-30	$716.33M	18.01%
2006-06-30	$607.00M	42.65%
2005-06-30	$425.50M	25.39%
2004-06-30	$339.34M	24.04%
2003-06-30	$273.57M	34.05%
2002-06-30	$204.08M	31.53%
2001-06-30	$155.16M	34.20%
2000-06-30	$115.61M	30.49%
1999-06-30	$88.60M	33.23%
1998-06-30	$66.50M	35.16%
1997-06-30	$49.20M	42.20%
1996-06-30	$34.60M	47.23%
1995-06-30	$23.50M	69.06%
1994-06-30	$13.90M	80.52%
1993-06-30	$7.70M	-

ResMed generated $4.69B in revenue during NA 2024, up 10.95% compared to the previous quarter, and up 179.75% compared to the same period a year ago.

ResMed Revenue by Quarter

Date	Revenue	Change
2024-09-30	$1.22B	0.11%
2024-06-30	$1.22B	2.19%
2024-03-31	$1.20B	2.94%
2023-12-31	$1.16B	20.74%
2023-09-30	$963.04M	-14.17%
2023-06-30	$1.12B	0.46%
2023-03-31	$1.12B	8.04%
2022-12-31	$1.03B	8.78%
2022-09-30	$950.29M	3.89%
2022-06-30	$914.74M	5.81%
2022-03-31	$864.50M	-3.39%
2021-12-31	$894.87M	-1.01%
2021-09-30	$904.01M	3.19%
2021-06-30	$876.10M	13.96%
2021-03-31	$768.77M	-3.91%
2020-12-31	$800.01M	6.39%
2020-09-30	$751.94M	-2.39%
2020-06-30	$770.34M	0.12%
2020-03-31	$769.46M	4.52%
2019-12-31	$736.16M	8.09%
2019-09-30	$681.06M	-3.39%
2019-06-30	$704.96M	6.45%
2019-03-31	$662.23M	1.71%
2018-12-31	$651.10M	10.68%
2018-09-30	$588.28M	-5.67%
2018-06-30	$623.63M	5.41%
2018-03-31	$591.63M	-1.60%
2017-12-31	$601.27M	14.82%
2017-09-30	$523.66M	-5.93%
2017-06-30	$556.69M	8.26%
2017-03-31	$514.20M	-3.05%
2016-12-31	$530.40M	13.95%
2016-09-30	$465.45M	-10.26%
2016-06-30	$518.65M	14.27%
2016-03-31	$453.88M	-0.15%
2015-12-31	$454.54M	10.42%
2015-09-30	$411.65M	-9.14%
2015-06-30	$453.06M	7.23%
2015-03-31	$422.50M	-0.11%
2014-12-31	$422.95M	11.19%
2014-09-30	$380.40M	-8.38%
2014-06-30	$415.21M	4.39%
2014-03-31	$397.76M	3.49%
2013-12-31	$384.34M	7.46%
2013-09-30	$357.66M	-13.73%
2013-06-30	$414.61M	8.09%
2013-03-31	$383.58M	1.87%
2012-12-31	$376.54M	10.83%
2012-09-30	$339.73M	-8.66%
2012-06-30	$371.93M	6.55%
2012-03-31	$349.07M	4.91%
2011-12-31	$332.74M	5.71%
2011-09-30	$314.77M	-7.93%
2011-06-30	$341.89M	9.14%
2011-03-31	$313.26M	2.38%
2010-12-31	$305.99M	8.50%
2010-09-30	$282.01M	-3.28%
2010-06-30	$291.57M	4.63%
2010-03-31	$278.66M	1.28%
2009-12-31	$275.13M	11.39%
2009-09-30	$246.99M	-1.97%
2009-06-30	$251.96M	10.57%
2009-03-31	$227.87M	2.19%
2008-12-31	$222.98M	2.32%
2008-09-30	$217.93M	-7.32%
2008-06-30	$235.15M	11.01%
2008-03-31	$211.83M	-

ResMed generated $1.22B in revenue during Q1 2025, up 0.11% compared to the previous quarter, and up 109.13% compared to the same period a year ago.

ResMed Revenue Breakdown

ResMed Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Jun 23	Jun 22	Jun 21	Jun 20	Jun 19
Software As A Service	$497.98M	-	-	-	-
Software As Service	$497.98M	$400.83M	$373.59M	$354.63M	$275.80M
Sleep And Respiratory	$3.73B	$3.18B	$2.82B	$2.60B	-
Masks	-	-	-	-	$677.40M
Devices	-	-	-	-	$743.10M
Devices And Masks	-	-	-	-	$910.30M

ResMed's latest annual revenue breakdown by segment (product or service), as of Jun 23: Sleep And Respiratory (78.90%), Software As A Service (10.55%), and Software As Service (10.55%).

Quarterly Revenue by Product

Product/Service	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19
Software As Service	$147.96M	$144.95M	$139.28M	$136.78M	$116.76M	$105.85M	$101.14M	$99.03M	$97.52M	$95.78M	$91.48M	$89.56M	$86.71M	$86.90M	$85.20M	$79.90M	-	-	-	-
Sleep And Respiratory	$1.05B	$1.02B	$963.04M	$983.48M	$980.12M	$916.98M	$844.44M	$763.36M	$795.84M	$806.50M	$780.33M	$674.93M	$708.18M	$659.80M	-	-	-	-	-	-
Devices And Masks	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$678.87M	$679.89M	$649.45M	$594.20M	$619.80M	$582.30M
Software As Service Before Deferred Revenue Adjustment	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$91.48M	$89.56M	$87.36M	$88.30M	$86.20M	$82.20M
Masks	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$245.80M
Devices	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$336.50M

ResMed's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Sleep And Respiratory (87.64%), and Software As Service (12.36%).

ResMed Revenue Breakdown by Country

Annual Revenue by Country

Country	Jun 23	Jun 22	Jun 21	Jun 20	Jun 19
Global	$1.50B	$3.58B	$3.20B	$2.96B	$2.61B
U [S]	$2.72B	-	-	-	-
Rest Of World	$1.50B	-	-	-	-
UNITED STATES	$2.72B	-	-	-	-
U.s. Canada And Latin America	-	$2.38B	$2.08B	$1.93B	$1.70B

ResMed's latest annual revenue breakdown by geography, as of Jun 23: U [S] (32.20%), UNITED STATES (32.20%), Global (17.80%), and Rest Of World (17.80%).

Quarterly Revenue by Country

Country	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Jun 19	Mar 19
Global	$1.22B	$1.20B	$1.16B	$1.10B	$1.12B	$136.78M	$116.76M	$105.85M	$914.74M	$101.14M	$99.03M	$97.52M	$876.10M	$93.84M	$91.83M	$92.14M	$770.34M	$89.56M	$705.00M	$79.90M
Us Canada And Latin America	$707.31M	$687.47M	$669.33M	$638.36M	$257.07M	$269.73M	$105.85M	$101.14M	$99.03M	$97.52M	$93.84M	$91.83M	$92.14M	$89.56M	$79.90M	-	-	-	-	-
Combined Europe Asia And Other Markets	$360.43M	$361.55M	$348.52M	$324.68M	$115.16M	$104.45M	$266.34M	$287.93M	$309.03M	$315.46M	$99.21M	$93.42M	$80.62M	$91.31M	$77.10M	-	-	-	-	-

ResMed's latest quarterly revenue breakdown by geography, as of Sep 24: Global (53.42%), Us Canada And Latin America (30.86%), and Combined Europe Asia And Other Markets (15.72%).

ResMed Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
BDX	Becton, Dickinson and Company	$19.37B	$4.99B
BAX	Baxter	$14.81B	$3.81B
ALC	Alcon	$10.09B	$2.46B
RMD	ResMed	$4.69B	$1.22B
HOLX	Hologic	$4.03B	$1.01B
COO	Cooper Companies	$3.59B	$1.00B
TFX	Teleflex	$2.97B	$764.38M
WST	West Pharmaceutical Services	$2.95B	$746.90M
ICUI	ICU Medical	$2.26B	$589.13M
MMSI	Merit Medical Systems	$1.26B	$339.85M
EMBC	Embecta	$1.12B	$272.50M
STAA	STAAR Surgical Company	$322.42K	$88.59M

RMD Revenue FAQ

What is ResMed’s yearly revenue?

ResMed's yearly revenue for 2024 was $4.69B, representing an increase of 10.95% compared to 2023. The company's yearly revenue for 2023 was $4.22B, representing an increase of 18.02% compared to 2022. RMD's yearly revenue for 2022 was $3.58B, representing an increase of 11.93% compared to 2021.

What is ResMed’s quarterly revenue?

ResMed's quarterly revenue for Q1 2025 was $1.22B, a 0.11% increase from the previous quarter (Q4 2024), and a 27.15% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $1.22B, a 2.19% increase from the previous quarter (Q3 2024), and a 9.01% increase year-over-year (Q4 2023). RMD's quarterly revenue for Q3 2024 was $1.2B, a 2.94% increase from the previous quarter (Q2 2024), and a 7.17% increase year-over-year (Q3 2023).

What is ResMed’s revenue growth rate?

ResMed's revenue growth rate for the last 3 years (2022-2024) was 30.94%, and for the last 5 years (2020-2024) was 58.45%.

What are ResMed’s revenue streams?

ResMed's revenue streams in n 23 are Software As A Service, Software As Service, and Sleep And Respiratory. Software As A Service generated $497.98M in revenue, accounting 10.55% of the company's total revenue Software As Service generated $497.98M in revenue, accounting 10.55% of the company's total revenue, up 24.24% year-over-year. Sleep And Respiratory generated $3.73B in revenue, accounting 78.90% of the company's total revenue, up 17.24% year-over-year.

What is ResMed’s main source of revenue?

For the fiscal year ending Jun 23, the largest source of revenue of ResMed was Sleep And Respiratory. This segment made a revenue of $3.73B, representing 78.90% of the company's total revenue.